Advertisement

Terminalia chebula Retz. Fruit Extracts Inhibit Bacterial Triggers of Some Autoimmune Diseases and Potentiate the Activity of Tetracycline

  • Aaron Mandeville
  • Ian Edwin Cock
Original Research Article
  • 6 Downloads

Abstract

Terminalia chebula Retz. is a northern Indian plant species known for its anti-inflammatory and antimicrobial properties. T. chebula fruit powder was extracted with solvents of varying polarity and screened for bacterial growth inhibition by disc diffusion assay. The minimum inhibitory concentration (MIC) was quantified by both liquid dilution and disc diffusion techniques. To screen for combinatorial effects, the T. chebula fruit extracts were combined with a range of conventional antibiotics and tested against each bacteria using a liquid dilution assay. Where synergy was detected, the optimal ratios were determined using isobologram analysis. Toxicity was examined using Artemia nauplii and HDF bioassays. T. chebula fruit methanolic, aqueous and ethyl acetate extracts displayed strong antimicrobial activity against the bacterial triggers of all autoimmune inflammatory diseases except K. pneumoniae, for which only moderate inhibition was observed. Indeed, MIC values as low as 195 μg/mL were measured for the aqueous extract against a resistant strain of P. aeruginosa. Of further note, both the aqueous and ethyl acetate extracts interacted synergistically in combination with tetracycline against K. pneumoniae (Σ FIC 0.38 and 0.25 respectively). All extracts were nontoxic in the Artemia and HDF toxicity assays, further indicating their potential for medicinal use.

Keywords

Synergy Multi-drug resistant bacteria Combinational therapies Rheumatoid arthritis Ankylosing spondylitis Multiple sclerosis 

Abbreviations

ALA

Brine-shrimp lethality assay

DMSO

Dimethyl sulfoxide

HDF

Human dermal fibroblasts

INT

ρ-iodonitrotetrazolium chloride

LD50

Dose of sample necessary to have a lethal effect on 50% of test organisms or cells

MIC

Minimum inhibitory concentration

ΣFIC

The sum of the fractional inhibitory concentration

Notes

Acknowledgements

We are most grateful to Dr Paran Rayan for supplying the plant materials used in this study. Financial support for this work was provided by the Environmental Futures Research Institute and the School of Natural Sciences, Griffith University, Australia.

References

  1. 1.
    Cheesman MJ, Ilanko A, Blonk B, Cock IE (2017) Developing new antimicrobial therapies: are synergistic combinations of plant extracts/compounds with conventional antibiotics the solution? Pharmacog Rev 11:57–72.  https://doi.org/10.4103/phrev.phrev_21_17 CrossRefGoogle Scholar
  2. 2.
    WHO (2016) Antimicrobial resistance. World Health Organization. http://www.who.int/mediacentre/factsheets/fs194/en/. Last cited on 2017 May 10
  3. 3.
    Sirdaarta J, Matthews B, Cock IE (2015) Kakadu plum fruit extracts inhibit the growth of the bacterial triggers of rheumatoid arthritis: identification of stilbene and tannin components. J Funct Food 17:610–620.  https://doi.org/10.1016/j.jff.2015.06.019 CrossRefGoogle Scholar
  4. 4.
    Ilanko A, Cock IE (2018) The interactive antimicrobial activity of contentional antibiotics and Petalostigma spp. extracts against bacterial triggers of some autoimmune inflammatory diseases. BMC Complement Alt Med (in press)Google Scholar
  5. 5.
    Chowdhury AN, Ashrafuzzaman M, Ali H, Liza LN, Zinnah KMA (2013) Antimicrobial activity of some medicinal plants against multi drug resistant human pathogens. Adv Biosci Bioeng 1:1–24Google Scholar
  6. 6.
    Cock IE (2015) The medicinal properties and phytochemistry of plants of the genus Terminalia (Combretaceae). Inflammopharmacol 23:203–229.  https://doi.org/10.1007/s10787-015-0246-z CrossRefGoogle Scholar
  7. 7.
    Belapurkar P, Goyal P, Tiwari-Barua P (2014) Immunomodulatory effects of Triphala and its individual constituents: a review. Indian J Pharm Sci 76:467–475PubMedPubMedCentralGoogle Scholar
  8. 8.
    Dhiman R, Aggarwal N, Aneja KR, Kaur M (2016) In vitro antimicrobial activity of spices and medicinal herbs against selected microbes associated with juices. Int J Microbiol 2016:9.  https://doi.org/10.1155/2016/9015802 CrossRefGoogle Scholar
  9. 9.
    Chainani S, Siddana S, Reddy C, Thippeswamy M, Maurya M, Rudraswamy S (2015) Antimicrobial activity of Triphala on Lactobacilli and Candida albicans: an in vitro study. J Orofac Sci 7:104–107.  https://doi.org/10.4103/0975-8844.169757 CrossRefGoogle Scholar
  10. 10.
    Bag A, Bhattacharyya SK, Chattopadhyay RR (2013) The development of Terminalia chebula Retz. (Combretaceae) in clinical research. Asian Pac J Trop Med 3:244–252.  https://doi.org/10.1016/S2221-1691(13)60059-3 CrossRefGoogle Scholar
  11. 11.
    Juang LJ, Sheu SJ, Lin TC (2004) Determination of hydrolyzable tannins in the fruit of Terminalia chebula Retz. by high-performance liquid chromatography and capillary electrophoresis. J Sep Sci 27:718–724.  https://doi.org/10.1002/jssc.200401741 CrossRefPubMedGoogle Scholar
  12. 12.
    Courtney R, Sirdaarta J, Matthews B, Cock IE (2015) Tannin components and inhibitory activity of Kakadu plum leaf extracts against microbial triggers of autoimmune inflammatory diseases. Pharmacog J 7:18–31.  https://doi.org/10.5530/pj.2015.7.2 CrossRefGoogle Scholar
  13. 13.
    Cock IE, Cheesman M (2018) The potential of plants of the genus Syzygium (Myrtaceae) for the prevention and treatment of arthritic and autoimmune diseases. In: Preedy VR, Watson RR (eds) Bioactive foods as dietary interventions for arthritis, osteoarthritis, and related autoimmune siseases, 2nd edn. Elsevier, NetherlandsGoogle Scholar
  14. 14.
    Boyer H, Cock IE (2013) Evaluation of the potential of Macademia integriflora extracts as antibacterial food agents. Pharmacog Commun 3:53–62.  https://doi.org/10.5530/pc.2013.3.10 Google Scholar
  15. 15.
    Vesoul J, Cock IE (2012) The potential of Bunya nut as an antibacterial food agent. Pharmacog Commun 2:72–79.  https://doi.org/10.5530/pc.2012.1.13 CrossRefGoogle Scholar
  16. 16.
    Winnett V, Boyer H, Sirdaarta J, Cock IE (2014) The potential of Tasmannia lanceolata as a natural preservative and medicinal agent: antimicrobial activity and toxicity. Pharmacog Commun 4:42–52.  https://doi.org/10.5530/pc.2014.1.7 CrossRefGoogle Scholar
  17. 17.
    Cock IE, van Vuuren SF (2014) Anti-Proteus activity of some South African medicinal plants: their potential for the treatment and prevention of rheumatoid arthritis. Inflammopharmacol 22:23–36.  https://doi.org/10.1007/s10787-013-0179-3 CrossRefGoogle Scholar
  18. 18.
    Eloff JN (1998) A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria. Planta Med 64:711–713.  https://doi.org/10.1055/s-2006-957563 CrossRefPubMedGoogle Scholar
  19. 19.
    Hubsch Z, Van Zyl RL, Cock IE, Van Vuuren SF (2014) Interactive antimicrobial and toxicity profiles of conventional antimicrobials with Southern African medicinal plants. S Afr J Bot 93:185–197.  https://doi.org/10.1016/j.sajb.2014.04.005 CrossRefGoogle Scholar
  20. 20.
    Arkhipov A, Sirdaarta J, Rayan P, McDonnell PA, Cock IE (2014) An examination of the antibacterial, antifungal, anti-Giardial and anticancer properties of Kigelia africana fruit extracts. Pharmacog Commun 4:62–76.  https://doi.org/10.5530/pc.2014.3.7 CrossRefGoogle Scholar
  21. 21.
    Ruebhart DR, Wickramasinghe W, Cock IE (2009) Protective efficacy of the antioxidants vitamin E and Trolox™ against Microcystis aeruginosa, microcystin-LR and menadione toxicity in Artemia franciscana nauplii. J Toxicol Environ Health A 72:1567–1575CrossRefPubMedGoogle Scholar
  22. 22.
    Vesoul J, Cock IE (2011) An examination of the medicinal potential of Pittosporum phylloraeoides: toxicity, antibacterial and antifungal activities. Pharmacog Commun 1:8–17.  https://doi.org/10.5530/pc.2011.2.3 CrossRefGoogle Scholar
  23. 23.
    Shalom J, Cock IE (2018) Terminalia ferdinandiana Exell. fruit and leaf extracts inhibit proliferation and induce apoptosis in selected human cancer cell lines. Nutr Cancer.  https://doi.org/10.1080/01635581.2018.1460680 PubMedGoogle Scholar
  24. 24.
    Ekambaram SP, Perumal SS, Balakrishnan A (2016) Scope of hydrolysable tannins as possible antimicrobial agents. Phytother Res 30:1035–1045.  https://doi.org/10.1002/ptr.5616 CrossRefPubMedGoogle Scholar
  25. 25.
    Shin WS (2016) Combination antibacterial therapy against β-lactam drug resistance. ProQuest Dissertations Publishing. https://conservancy.umn.edu/handle/11299/182200. Last cited on 2018 April 24
  26. 26.
    Ba XL, Harrison EM, Lovering AL, Gleadall N, Zadoks R, Parkhill J, Peacock SJ, Holden MT, Paterson GK, Holmes MA (2015) Old drugs to treat resistant bugs: methicillin-resistant Staphylococcus aureus isolates with mecC are susceptible to a combination of penicillin and clavulanic acid. Antimicrob Agents Chemother 59:7396–7404.  https://doi.org/10.1128/AAC.01469-15 CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Parveen RM, Khan MA, Menezes GA, Harish BN, Parija SC, Hays JP (2011) Extended-spectrum β-lactamase producing Klebsiella pneumoniae from blood cultures in Puducherry, India. Indian J Med Res 134:392–395PubMedPubMedCentralGoogle Scholar
  28. 28.
    Sun JJ, Deng ZQ, Yan AX (2014) Bacterial multidrug efflux pumps: mechanisms, physiology and pharmacological exploitations. Biochem Biophys Res Commun 453:254–267.  https://doi.org/10.1016/j.bbrc.2014.05.090 CrossRefPubMedGoogle Scholar
  29. 29.
    Wang W, Guo Q, Xu X, Z-k Sheng, Ye X, Wang M (2014) High-level tetracycline resistance mediated by efflux pumps Tet(A) and Tet(A)-1 with two start codons. J Med Microbiol 63:1454–1459.  https://doi.org/10.1099/jmm.0.078063-0 CrossRefPubMedGoogle Scholar
  30. 30.
    Weinstein RA, Hooper DC (2005) Efflux pumps and nosocomial antibiotic resistance: a primer for hospital epidemiologists. Clin Infect Dis 40:1811–1817.  https://doi.org/10.1086/430381 CrossRefGoogle Scholar
  31. 31.
    Bag A, Chattopadhyay RR (2014) Efflux-pump inhibitory activity of a gallotannin from Terminalia chebula fruit against multidrug-resistant uropathogenic Escherichia coli. Nat Prod Res 28:1280–1283.  https://doi.org/10.1080/14786419.2014.895729 CrossRefPubMedGoogle Scholar
  32. 32.
    Chusri S, Villanueva I, Voravuthikunchai SP, Davies J (2009) Enhancing antibiotic activity: a strategy to control Acinetobacter infections. J Antimicrob Chemother 64:1203–1211.  https://doi.org/10.1093/jac/dkp381 CrossRefPubMedGoogle Scholar
  33. 33.
    Oteo J, Campos J, Lázaro E, Cuevas O, Garcia-Cobos S, Pérez-Vázquez M, de Abajo FJ, Spanish Members of EARSS (2008) Increased amoxicillin-clavulanic acid resistance in Escherichia coli blood isolates, Spain. Emerg Infect Dis 14:1259–1262CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Association of Microbiologists of India 2018

Authors and Affiliations

  1. 1.School of Natural Sciences, Nathan CampusGriffith UniversityNathanAustralia
  2. 2.Environmental Futures Research Institute, Nathan CampusGriffith UniversityNathanAustralia

Personalised recommendations